These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4375330)

  • 1. Surface-immobilized prostaglandin as a platelet protective agent.
    Grode GA; Pitman J; Crowley JP; Leininger RI; Falb RD
    Trans Am Soc Artif Intern Organs; 1974; 20A():38-41. PubMed ID: 4375330
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandin E1 and platelets.
    Bousser MG
    Biomedicine; 1973 Mar; 18(2):95-102. PubMed ID: 4354464
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 3. Significance of prostaglandins and cAMP for aggregation inhibiting effect and other effects of sulfonylurea compounds].
    Scholz VC; Hoder A; Losert W
    Arzneimittelforschung; 1975 Mar; 25(3):347-61. PubMed ID: 239727
    [No Abstract]   [Full Text] [Related]  

  • 4. [Platelet aggregation and cyclic AMP].
    Ukita M
    Rinsho Byori; 1972 Nov; 20(11):805-9. PubMed ID: 4347154
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of prostaglandins E1 and E2 on platelet aggregation in mammals.
    Sinakos Z; Zamboulis C; Kartalis G; Koratzis J; Valtis D
    Haematologica; 1974 Jun; 59(2):173-80. PubMed ID: 4216529
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental studies on mechanism of inhibition of thrombocyte aggregation caused by sulfonyl ureas. 1. Problems and methods].
    Scholz Ch; Losert W; Hoder A
    Arzneimittelforschung; 1975 Jan; 25(1):38-46. PubMed ID: 167791
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of platelet adherence to protein-coated surfaces.
    Jenkins CS; Packham MA; Guccione MA; Mustard JF
    J Lab Clin Med; 1973 Feb; 81(2):280-90. PubMed ID: 4118983
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of platelet aggregation by 2-(p-chlorophenyl)-4-thiazoleacrylic acid (Wy-23,049)--comparison with acetylsalicylic acid.
    Fenichel RL; Dougherty JA; Alburn HE
    Biochem Pharmacol; 1974 Dec; 23(23):3273-82. PubMed ID: 4374215
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet accumulation on fibrinogen-blockade of the prostaglandin and ADP pathways.
    Feuerstein IA; Dickson VM
    Trans Am Soc Artif Intern Organs; 1982; 28():437-43. PubMed ID: 7164277
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of temperature and preservation of plasma on platelet aggregation induced with ADP in the presence of prostaglandin E1].
    Bottecchia D
    Arch Fisiol; 1972 Oct; 69(2):160-70. PubMed ID: 4677537
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of the 3',5'-cyclic phosphates of 2-methylthioadenosine, 2-chloroadenosine and adenosine on platelet aggregation.
    Maguire MH; Penglis-Caredes F; Gough GR
    Experientia; 1974 Aug; 30(8):922-4. PubMed ID: 4369976
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions of the pharmacological receptors of blood platelets with adenylate cyclase.
    Haslam RJ
    Ser Haematol; 1973; 6(3):333-50. PubMed ID: 4360127
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic AMP and platelet aggregation.
    Hugues J
    Acta Univ Carol Med Monogr; 1972; 53():179-84. PubMed ID: 4364682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of prostaglandin E1 on in vitro and in vivo platelet aggregation with special reference to thrombus formation (author's transl)].
    Kobayashi N; Araki H
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):166-73. PubMed ID: 4471800
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on platelet aggregation inhibitory agents (author's transl)].
    Ukita M; Kitahara T; Hosokawa T; Kato M; Suzuki Y; Otomo H
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):161-5. PubMed ID: 4369675
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of PGE1 on ADP-induced aggregation in refractory platelets.
    Simard-Duquesne N; Dvornik D
    Prostaglandins; 1973 Apr; 3(4):457-60. PubMed ID: 4354089
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
    Evans RJ; Gordon JL
    Br J Pharmacol; 1974 May; 51(1):123P. PubMed ID: 4441772
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of dilazep on platelet aggregation.
    Nakajima K; Shirai K; Takimoto M; Satoh F; Aoki M
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1899-901. PubMed ID: 4480271
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of prostaglandin E1 on experimental thrombosis and platelet aggregation in rabbits.
    Bousser MG; Lecrubier C
    Haemostasis; 1972-1973; 1(5):294-303. PubMed ID: 4670122
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanisms of action of prostaglandins on the thrombocyte-vascular wall system].
    Gabrielian ES; Akopov SE; Badzhinian SA
    Vestn Akad Med Nauk SSSR; 1984; (11):63-8. PubMed ID: 6099016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.